FELBATOL Side Effects

7029957-X | Abdominal Pain Upper, Chest Pain, Decreased Appetite, Diarrhoea, Hypomenorrhoea, Nausea, Weight Decreased
on Nov 12, 2009 Female patient from UNITED STATES , 44 years of age, weighting 207.0 lb, was diagnosed with petit mal epilepsy and was treated with Felbatol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, chest pain (What is chest pain?), decreased appetite, diarrhoea, hypomenorrhoea, nausea (What is nausea?), weight decreased. Felbatol dosage: 1800 Mg (600 Mg, 3 In 1 D), Oral 1200 Mg, (600 Mg, 2 In 1 D), Oral. During the same period patient was treated with TOPAMAX (TOPIRAMTATE) (View Topamax (topiramtate) Review and Topamax (topiramtate) Label ), TEGRETOL (View Tegretol Review and Tegretol Label ).

7023487-7 | Myoclonic Epilepsy, Psychomotor Hyperactivity, Tremor
Patient was taking Felbatol (View Usage). Patient had the following side effects: myoclonic epilepsy, psychomotor hyperactivity, tremor on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 15 years of age, weighting 138.0 lb, was diagnosed with myoclonic epilepsy and. Felbatol dosage: 400 Mg (200 Mg, 2 In 1 D) Oral; 800 Mg Daily Oral; 1000 Mg Daily Oral; 900 Mg (300 Mg, 3 In 1 D) Ora.

6458946-9 | Abnormal Behaviour, Aggression, Anger, Personality Change
Adverse event was reported on Nov 25, 2009 by a Male patient taking Felbatol (View Usage) (Dosage: 100 Mg 2 Am, 2 Noon, 2 Pm) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED STATES , 36 years of age, weighting 188.0 lb, After Felbatol was administered, patient had the following side effects: abnormal behaviour, aggression, anger, personality change.

6140467-4 | Catatonia, Cognitive Disorder, Hypoaesthesia, Hypoaesthesia Oral, Throat Tightness, Tremor
on Mar 20, 2009 Female patient from UNITED STATES , 21 years of age, was treated with Felbatol (View Usage). Patient experienced the following unwanted or unexpected effects: catatonia, cognitive disorder, hypoaesthesia, hypoaesthesia oral, throat tightness, tremor. Felbatol dosage: 900 Mg (300 Mg, 3 In 1 D), Oral. During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), ZARONTIN (View Zarontin Review and Zarontin Label ).


6050766-2 | Asthenia, Convulsion, Dysstasia, Pancytopenia
on Jan 21, 2009 Male patient from UNITED STATES , weighting 219.0 lb, was diagnosed with convulsion and was treated with Felbatol (View Usage). Patient had the following side effects: asthenia, convulsion, dysstasia, pancytopenia. Felbatol dosage: 1600mg Tid Po. Patient was hospitalized.

5928906-2 | Decreased Appetite, Nausea, Neutropenia, Platelet Count Decreased, Weight Decreased
Patient was taking Felbatol (View Usage). After Felbatol was administered, patient had the following side effects: decreased appetite, nausea (What is nausea?), neutropenia, platelet count decreased, weight decreased on Mar 17, 2008 from UNITED STATES Additional patient health information: Male patient , 13 years of age, weighting 95.00 lb, was diagnosed with epilepsy (What is epilepsy?) and. Felbatol dosage: (3300 Mg,1200 Mg Am + 900 Mg Midday + 1200 Mg Pm),oral. During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ).

5928901-3 | Adrenal Insufficiency, Agranulocytosis, Cardiac Failure Congestive, Diarrhoea, Ear Pain, Lung Injury, Pancytopenia, Rash, Sepsis
Adverse event was reported on Oct 02, 2007 by a Female patient taking Felbatol (View Usage) (Dosage: (900-600-300 In Divided Doses Per Day)) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED STATES , 18 years of age, weighting 125.7 lb, Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, agranulocytosis, cardiac failure congestive, diarrhoea, ear pain, lung injury, pancytopenia, rash (What is rash?), sepsis (What is sepsis?). During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), KEPPRA (View Keppra Review and Keppra Label ), KLONOPIN (View Klonopin Review and Klonopin Label ). Patient was hospitalized.

5781159-0 | Bronchiolitis, Dehydration, Gastroenteritis Viral, Hypokalaemia, Ketoacidosis, Metabolic Acidosis, Pneumonia, Raynaud's Phenomenon, Red Blood Cell Abnormality
on Jun 10, 2008 Female patient from UNITED STATES , child 2 years of age, was diagnosed with lennox-gastaut syndrome and was treated with Felbatol (View Usage). Patient had the following side effects: bronchiolitis, dehydration, gastroenteritis viral, hypokalaemia, ketoacidosis, metabolic acidosis, pneumonia (What is pneumonia?), raynaud's phenomenon, red blood cell abnormality. Felbatol dosage: 400mg Am And 200 Mg Pm ,oral. During the same period patient was treated with CALCIUM LIQUID (View Calcium Liquid Review and Calcium Liquid Label ), LEVOTHROID (View Levothroid Review and Levothroid Label ), VIGABATRIN (View Vigabatrin Review and Vigabatrin Label ), MIRLALAX (View Mirlalax Review and Mirlalax Label ), TYLENOL (View Tylenol Review and Tylenol Label ), SUGAR FREE VITAMIN (View Sugar Free Vitamin Review and Sugar Free Vitamin Label ). Patient was hospitalized.

5717184-5 | Dizziness, Dysarthria, Fall, Incorrect Dose Administered, Transient Ischaemic Attack, Wrist Fracture
on Apr 15, 2008 Female patient from UNITED STATES , 62 years of age, weighting 200.0 lb, was diagnosed with convulsion and was treated with Felbatol (View Usage). After Felbatol was administered, patient had the following side effects: dizziness (What is dizziness?), dysarthria, fall (What is fall?), incorrect dose administered, transient ischaemic attack, wrist fracture. Felbatol dosage: (1800mg And 3 Pm, And 2400mg Hs) Oral. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

5656164-5 | Dizziness Postural, Dysarthria, Fall, Incorrect Dose Administered, Transient Ischaemic Attack, Wrist Fracture
Patient was taking Felbatol (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness postural, dysarthria, fall (What is fall?), incorrect dose administered, transient ischaemic attack, wrist fracture on Feb 22, 2008 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 200.0 lb, was diagnosed with convulsion and. Felbatol dosage: (1800 Mg Am And 3 Pm And 2400mg Pm), Oral. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), OXYDOCONE (View Oxydocone Review and Oxydocone Label ). Patient was hospitalized.

5654433-6 | Dehydration, Gastrointestinal Infection, Ketoacidosis, Pneumonia, Raynaud's Phenomenon, Respiratory Syncytial Virus Infection, Thyroid Disorder, Viral Infection, Vomiting
Adverse event was reported on Feb 19, 2008 by a Female patient taking Felbatol (View Usage) (Dosage: (400mg Am And 200 Mg Pm), Oral) was diagnosed with lennox-gastaut syndrome and. Location: UNITED STATES , child 2 years of age, Patient had the following side effects: dehydration, gastrointestinal infection, ketoacidosis, pneumonia (What is pneumonia?), raynaud's phenomenon, respiratory syncytial virus infection (What is respiratory syncytial virus infection?), thyroid disorder, viral infection (What is viral infection?), vomiting. During the same period patient was treated with CALCIUM LIQUID (View Calcium Liquid Review and Calcium Liquid Label ), LEVOTHROID (View Levothroid Review and Levothroid Label ), VIGABATRIN (View Vigabatrin Review and Vigabatrin Label ), MIRALAX (View Miralax Review and Miralax Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), SUGAR FREE VITAMIN (View Sugar Free Vitamin Review and Sugar Free Vitamin Label ). Patient was hospitalized.

5488160-5 | Neutrophil Count Decreased, Reticulocyte Count Decreased, White Blood Cell Count Decreased
on Apr 18, 2007 Male patient from UNITED STATES , child 10 years of age, was diagnosed with lennox-gastaut syndrome and was treated with Felbatol (View Usage). After Felbatol was administered, patient had the following side effects: neutrophil count decreased, reticulocyte count decreased, white blood cell count decreased. Felbatol dosage: . During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), KEPPRA (View Keppra Review and Keppra Label ), KLONOPIN (View Klonopin Review and Klonopin Label ).

5488158-7 | Hyponatraemia
on Jun 28, 2007 Male patient from UNITED STATES , child 6 years of age, was diagnosed with ill-defined disorder and was treated with Felbatol (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia. Felbatol dosage: 1200 Mg (1200 Mg, 1 In 1 D), Po; Winter 2006. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ). Patient was hospitalized.

5488154-X | Neutropenia
Patient was taking Felbatol (View Usage). Patient had the following side effects: neutropenia on May 01, 2007 from UNITED STATES Additional patient health information: Male patient , child 3 years of age, weighting 39.68 lb, was diagnosed with lennox-gastaut syndrome and. Felbatol dosage: 8 Milliliter (4 Milliliter, 2 In 1 D), Po. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ).

5488152-6 | Neutropenia
Adverse event was reported on Feb 20, 2007 by a Male patient taking Felbatol (View Usage) (Dosage: 800 Mg Tid, Po) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED STATES , 22 years of age, After Felbatol was administered, patient had the following side effects: neutropenia. During the same period patient was treated with DEPAKOTE (View Depakote Review and Depakote Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).

5480714-5 | Aplastic Anaemia, Blood Pressure Diastolic Decreased, Bone Marrow Failure, Dysfunctional Uterine Bleeding, Encephalitis Viral, Endometriosis, Epistaxis, Euthyroid Sick Syndrome, Grand Mal Convulsion
on Sep 27, 2007 Female patient from UNITED STATES , 14 years of age, weighting 125.0 lb, was diagnosed with status epilepticus and was treated with Felbatol (View Usage). Patient experienced the following unwanted or unexpected effects: aplastic anaemia, blood pressure diastolic decreased, bone marrow failure, dysfunctional uterine bleeding, encephalitis viral, endometriosis (What is endometriosis?), epistaxis, euthyroid sick syndrome, grand mal convulsion. Felbatol dosage: 3600 Mg (1200 Mg, 3 In 1 D). During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), KEPPRA (View Keppra Review and Keppra Label ), DILANTIN (View Dilantin Review and Dilantin Label ), PENTOBARBITAL CAP (View Pentobarbital Cap Review and Pentobarbital Cap Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

5475266-X | Aplastic Anaemia, Body Temperature Decreased, Heart Rate Increased, Infection, Pancytopenia, Platelet Count Increased, Respiratory Rate Increased, White Blood Cell Count Increased
on Sep 12, 2007 Female patient from UNITED STATES , 14 years of age, weighting 125.0 lb, was diagnosed with status epilepticus and was treated with Felbatol (View Usage). Patient had the following side effects: aplastic anaemia, body temperature decreased, heart rate increased, infection (What is infection?), pancytopenia, platelet count increased, respiratory rate increased, white blood cell count increased. Felbatol dosage: 3600 Mg (1200 Mg, 3 In 1 D). During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), KEPPRA (View Keppra Review and Keppra Label ), DILANTIN (View Dilantin Review and Dilantin Label ), PENTOBARBITAL CAP (View Pentobarbital Cap Review and Pentobarbital Cap Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

5449517-1 | Aplastic Anaemia, Platelet Count Decreased
Patient was taking Felbatol (View Usage). After Felbatol was administered, patient had the following side effects: aplastic anaemia, platelet count decreased on Aug 22, 2007 from UNITED STATES Additional patient health information: Female patient , 14 years of age, was diagnosed with status epilepticus and. Felbatol dosage: 3600 Mg (1200 Mg, 3 In 1 D). During the same period patient was treated with PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), KEPPRA (View Keppra Review and Keppra Label ), DILANTIN (View Dilantin Review and Dilantin Label ), PENTOBARBITAL CAP (View Pentobarbital Cap Review and Pentobarbital Cap Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

5281491-3 | Muscle Spasms
Adverse event was reported on Mar 23, 2007 by a Female patient taking Felbatol (View Usage) (Dosage: 400 Mg 3 Times Daily Po) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED STATES , weighting 130.0 lb, Patient experienced the following unwanted or unexpected effects: muscle spasms.

5216831-4 | Aplastic Anaemia, Enterobacter Sepsis, Fall, Head Injury
on Nov 16, 2006 Female patient from UNITED STATES , 42 years of age, was diagnosed with complex partial seizures and was treated with Felbatol (View Usage). Patient had the following side effects: aplastic anaemia, enterobacter sepsis, fall (What is fall?), head injury. Felbatol dosage: Po. Patient was hospitalized and became disabled.

5197388-3 | Blood Sodium Decreased, Vomiting
on Jun 28, 2006 Male patient from UNITED STATES , 16 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Felbatol (View Usage). After Felbatol was administered, patient had the following side effects: blood sodium decreased, vomiting. Felbatol dosage: 800 Mg Via J-tube (3 In 1 D). During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), ROBINAL (View Robinal Review and Robinal Label ). Patient was hospitalized.

5197387-1 | White Blood Cell Count Decreased
Patient was taking Felbatol (View Usage). Patient experienced the following unwanted or unexpected effects: white blood cell count decreased on Mar 29, 2006 from UNITED STATES Additional patient health information: Female patient , 24 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Felbatol dosage: . During the same period patient was treated with ZONEGRAN (View Zonegran Review and Zonegran Label ), KEPPRA (View Keppra Review and Keppra Label ), MIDRIN (MIDRID) (View Midrin (midrid) Review and Midrin (midrid) Label ), TRANXENE (View Tranxene Review and Tranxene Label ).

5197385-8 | Hepatitis, Infected Insect Bite, Status Epilepticus
Adverse event was reported on Aug 30, 2005 by a Female patient taking Felbatol (View Usage) (Dosage: 750 Mg Bid, P.o.) was diagnosed with partial seizures, infected insect bite and. Location: UNITED STATES , child 6 years of age, weighting 37.48 lb, Patient had the following side effects: hepatitis (What is hepatitis?), infected insect bite, status epilepticus. During the same period patient was treated with CEFTRIAXONE (Iv) (View Ceftriaxone Review and Ceftriaxone Label ), TOPAMAX (View Topamax Review and Topamax Label ), KEPPRA (View Keppra Review and Keppra Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ). Patient was hospitalized.

5189791-2 | Bacteraemia
on Dec 07, 2006 Male patient from UNITED STATES , weighting 16.80 lb, was diagnosed with infantile spasms and was treated with Felbatol (View Usage). After Felbatol was administered, patient had the following side effects: bacteraemia. Felbatol dosage: 2 Cc (3 In 1 D). During the same period patient was treated with TOPAMAX (View Topamax Review and Topamax Label ).

5096101-8 | Aplastic Anaemia, Bone Marrow Failure, Idiopathic Thrombocytopenic Purpura, Menorrhagia
on Aug 17, 2006 Female patient from UNITED STATES , 13 years of age, weighting 102.0 lb, was diagnosed with complex partial seizures and was treated with Felbatol (View Usage). Patient experienced the following unwanted or unexpected effects: aplastic anaemia, bone marrow failure, idiopathic thrombocytopenic purpura, menorrhagia. Felbatol dosage: 1600 Mg Bid (mg), Po. During the same period patient was treated with RITALIN 10 MG TID (METHYLPHENIDATE HYDROCHLORIDE) (View Ritalin 10 Mg Tid (methylphenidate Hydrochloride) Review and Ritalin 10 Mg Tid (methylphenidate Hydrochloride) Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized and became disabled.

5092159-0 | Anencephaly
Patient was taking Felbatol (View Usage). Patient had the following side effects: anencephaly on Aug 28, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 132.0 lb, was diagnosed with convulsion and. Felbatol dosage: 600 Mg Oral Tab Take Two And One. H Po. During the same period patient was treated with FELBAMATE (View Felbamate Review and Felbamate Label ).

5069108-4 | Disease Progression, Gastric Ulcer, Haemorrhage, Lennox-gastaut Syndrome, Pyrexia, Refusal Of Treatment By Relative
Adverse event was reported on Jul 18, 2006 by a Male patient taking Felbatol (View Usage) (Dosage: 38 Mg/kg/day) was diagnosed with lennox-gastaut syndrome, asthma (What is asthma?) and. Location: UNITED STATES , 17 years of age, weighting 50.71 lb, After Felbatol was administered, patient had the following side effects: disease progression, gastric ulcer, haemorrhage, lennox-gastaut syndrome, pyrexia, refusal of treatment by relative. During the same period patient was treated with CORTICOSTEROID (CORTICOSTEROIDS) (View Corticosteroid (corticosteroids) Review and Corticosteroid (corticosteroids) Label ), MYSOLINE (View Mysoline Review and Mysoline Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), TOPAMAX (View Topamax Review and Topamax Label ).

5032145-X | Convulsion, Fall, Laceration, Sleep Disorder
on Jun 08, 2006 Male patient from UNITED STATES , 30 years of age, was diagnosed with convulsion and was treated with Felbatol (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, fall (What is fall?), laceration, sleep disorder (What is sleep disorder?). Felbatol dosage: 2 Tablets Am, 2 Lunch, 2 Pm (400 Mg), Oral.

5009722-5 | Antibody Test Positive, Hepatic Steatosis, Hepatitis Cholestatic
on May 10, 2006 Female patient from UNITED STATES , 27 years of age, weighting 237.0 lb, was diagnosed with convulsion and was treated with Felbatol (View Usage). Patient had the following side effects: antibody test positive, hepatic steatosis, hepatitis cholestatic. Felbatol dosage: 900mg Bid, Oral. During the same period patient was treated with LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.